Warning: infection of genital area with SGLT2 inhibitors for diabetes
The U.S. Food and Drug Administration (FDA) is warning that cases of a rare but serious infection of the genitals and area around the genitals have been reported with the class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors.
www.fda.gov
SGLT2 inhibitors include drugs such as Farxiga, Jardiance, Xigduo, and Qtern.